Zobrazeno 1 - 10 of 128 pro vyhledávání: '"R, Loertscher"'
2
The failure of Daudi cells to express the cellular prion protein is caused by a lack of glycosyl-phosphatidylinositol anchor formation
Autor: E Morelon, P Lavery, Neil R. Cashman, Vincent Dodelet, R Loertscher
Publikováno v: Immunology. 102:242-247
The cellular prion protein (PrPc) is a glycosyl-phosphatidylinositol (GPI)-linked cell surface protein, which is expressed at high density on nervous tissues and at lower levels on most other solid-organ tissues. It is also expressed on peripheral bl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1d397374454735242842fda95e5e6096
https://doi.org/10.1046/j.1365-2567.2001.01166.x
Zobrazit plný text záznamu
3
Diabetes mellitus in transplantation: 2002 consensus guidelines
Autor: J.G Mongeau, B Kiberd, Jonathan Carter, R Loertscher, S.J Kim, A Boucher, L Vautour, G.V.R Prasad, R Moore
Publikováno v: Transplantation proceedings. 35(4)
Diabetes mellitus is a serious complication following organ transplantation that is underdiagnosed, possibly due to the inadequate definitions used in published literature and the lack of standardized screening. Diabetes in transplantation amplifies
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93894efdc4a44c7d8a91a9070e1a3ce7
https://pubmed.ncbi.nlm.nih.gov/12826134
Zobrazit plný text záznamu
5
Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy
Autor: M, Cantarovich, J G, Besner, J S, Barkun, E, Elstein, R, Loertscher
Publikováno v: Clinical transplantation. 12(3)
To assess the safety profile of Neoral dose adjustment using cyclosporine (CsA) trough levels (C0) compared with levels obtained 2 h after the morning dose (C2), 30 stable adult heart transplant patients 1 yr or more after surgery were converted from
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ee2abf289042762f1eddd112cbdf02d8
https://pubmed.ncbi.nlm.nih.gov/9642517
Zobrazit plný text záznamu
6
Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group
Autor: E, Cole, P, Keown, D, Landsberg, P, Halloran, A, Shoker, D, Rush, J, Jeffrey, D, Russell, C, Stiller, N, Muirhead, L, Paul, J, Zaltzman, R, Loertscher, P, Daloze, R, Dandavino, A, Boucher, P, Handa, J, Lawen, P, Belitsky, P, Parfrey, A, Tan, L, Hendricks
Publikováno v: Transplantation. 65(4)
There has been concern that the increased drug exposure associated with treatment with cyclosporine microemulsion (CsA-ME) would lead to an increase in adverse events.The long-term safety and tolerability of conventional cyclosporine (CsA) and CsA-ME
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::535b6f5d4c90fa50e2dca6e4b2f9584c
https://pubmed.ncbi.nlm.nih.gov/9500624
Zobrazit plný text záznamu
7
Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy
Autor: M, Cantarovich, D A, Latter, R, Loertscher
Publikováno v: Clinical transplantation. 11(4)
The purpose of this study was to assess the efficacy of short courses of OKT3 and ATG, respectively, for steroid resistant or recurrent acute allograft cardiac rejection (AR). Between June 1988 and March 1994, 101 heart transplant patients were treat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3ec6b163c75c1b552bcc8fa0956d4e85
https://pubmed.ncbi.nlm.nih.gov/9267721
Zobrazit plný text záznamu
8
Economic analysis of Neoral in de novo renal transplant patients in Canada
Autor: I, Kingma, D, Ludwin, R, Dandavino, J L, Wolff, R, Loertscher, L, Beauregard-Zollinger, P, Bacquet, S, Boucher, M, Rivière
Publikováno v: Clinical transplantation. 11(1)
This pilot economic evaluation was performed as part of the Canadian arm of an international randomized, controlled, double-blind safety and tolerability trial (OLM-105/NOF-2). The clinical study compared the safety and tolerability of a new microemu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::73a9464f990610f1ac63c1c8b02899e4
https://pubmed.ncbi.nlm.nih.gov/9067694
Zobrazit plný text záznamu
9
A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group
Autor: P, Keown, D, Landsberg, P, Halloran, A, Shoker, D, Rush, J, Jeffery, D, Russell, C, Stiller, N, Muirhead, E, Cole, L, Paul, J, Zaltzman, R, Loertscher, P, Daloze, R, Dandavino, A, Boucher, P, Handa, J, Lawen, P, Belitsky, P, Parfrey
Publikováno v: Transplantation. 62(12)
The safety, tolerability, and pharmacokinetics of conventional cyclosporine (ConCsA) and cyclosporine microemulsion (MeCsA) were compared under conditions of normal clinical practice in a prospective, randomized, concentration-controlled, pharmacoepi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c4e4f28978ecb6b03b579cda2118538b
https://pubmed.ncbi.nlm.nih.gov/8990355
Zobrazit plný text záznamu
10
Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts
Autor: R, Loertscher, R D, Forbes, G, Halabi, P, Lavery, T, Quinn
Publikováno v: Clinical transplantation. 8(3 Pt 1)
Monoclonal antibodies directed against early (receptors for interleukin-2 and transferrin [IL-2R, TfR]) and late (PTA1, alpha 1 integrin VLA-1) activation antigens were used as probes to monitor cardiac transplant patients for episodes of acute graft
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4465d9f7564fd55ac7db981ad14c3c6a
https://pubmed.ncbi.nlm.nih.gov/8061361
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje